Characterisation of serpin polymers in vitro and in vivo.

Neuroserpin is a member of the serine protease inhibitor or serpin superfamily of proteins. It is secreted by neurones and plays an important role in the regulation of tissue plasminogen activator at the synapse. Point mutations in the neuroserpin gene cause the autosomal dominant dementia familial...

Full description

Bibliographic Details
Main Authors: Belorgey, D, Irving, J, Ekeowa, U, Freeke, J, Roussel, B, Miranda, E, Pérez, J, Robinson, C, Marciniak, S, Crowther, D, Michel, C, Lomas, D
Format: Journal article
Language:English
Published: 2011
_version_ 1797079938357002240
author Belorgey, D
Irving, J
Ekeowa, U
Freeke, J
Roussel, B
Miranda, E
Pérez, J
Robinson, C
Marciniak, S
Crowther, D
Michel, C
Lomas, D
author_facet Belorgey, D
Irving, J
Ekeowa, U
Freeke, J
Roussel, B
Miranda, E
Pérez, J
Robinson, C
Marciniak, S
Crowther, D
Michel, C
Lomas, D
author_sort Belorgey, D
collection OXFORD
description Neuroserpin is a member of the serine protease inhibitor or serpin superfamily of proteins. It is secreted by neurones and plays an important role in the regulation of tissue plasminogen activator at the synapse. Point mutations in the neuroserpin gene cause the autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB. This is one of a group of disorders caused by mutations in the serpins that are collectively known as the serpinopathies. Others include α(1)-antitrypsin deficiency and deficiency of C1 inhibitor, antithrombin and α(1)-antichymotrypsin. The serpinopathies are characterised by delays in protein folding and the retention of ordered polymers of the mutant serpin within the cell of synthesis. The clinical phenotype results from either a toxic gain of function from the inclusions or a loss of function, as there is insufficient protease inhibitor to regulate important proteolytic cascades. We describe here the methods required to characterise the polymerisation of neuroserpin and draw parallels with the polymerisation of α(1)-antitrypsin. It is important to recognise that the conditions in which experiments are performed will have a major effect on the findings. For example, incubation of monomeric serpins with guanidine or urea will produce polymers that are not found in vivo. The characterisation of the pathological polymers requires heating of the folded protein or alternatively the assessment of ordered polymers from cell and animal models of disease or from the tissues of humans who carry the mutation.
first_indexed 2024-03-07T00:53:01Z
format Journal article
id oxford-uuid:870c0eaf-869a-47bd-80d5-42e1503417e1
institution University of Oxford
language English
last_indexed 2024-03-07T00:53:01Z
publishDate 2011
record_format dspace
spelling oxford-uuid:870c0eaf-869a-47bd-80d5-42e1503417e12022-03-26T22:08:09ZCharacterisation of serpin polymers in vitro and in vivo.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:870c0eaf-869a-47bd-80d5-42e1503417e1EnglishSymplectic Elements at Oxford2011Belorgey, DIrving, JEkeowa, UFreeke, JRoussel, BMiranda, EPérez, JRobinson, CMarciniak, SCrowther, DMichel, CLomas, DNeuroserpin is a member of the serine protease inhibitor or serpin superfamily of proteins. It is secreted by neurones and plays an important role in the regulation of tissue plasminogen activator at the synapse. Point mutations in the neuroserpin gene cause the autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB. This is one of a group of disorders caused by mutations in the serpins that are collectively known as the serpinopathies. Others include α(1)-antitrypsin deficiency and deficiency of C1 inhibitor, antithrombin and α(1)-antichymotrypsin. The serpinopathies are characterised by delays in protein folding and the retention of ordered polymers of the mutant serpin within the cell of synthesis. The clinical phenotype results from either a toxic gain of function from the inclusions or a loss of function, as there is insufficient protease inhibitor to regulate important proteolytic cascades. We describe here the methods required to characterise the polymerisation of neuroserpin and draw parallels with the polymerisation of α(1)-antitrypsin. It is important to recognise that the conditions in which experiments are performed will have a major effect on the findings. For example, incubation of monomeric serpins with guanidine or urea will produce polymers that are not found in vivo. The characterisation of the pathological polymers requires heating of the folded protein or alternatively the assessment of ordered polymers from cell and animal models of disease or from the tissues of humans who carry the mutation.
spellingShingle Belorgey, D
Irving, J
Ekeowa, U
Freeke, J
Roussel, B
Miranda, E
Pérez, J
Robinson, C
Marciniak, S
Crowther, D
Michel, C
Lomas, D
Characterisation of serpin polymers in vitro and in vivo.
title Characterisation of serpin polymers in vitro and in vivo.
title_full Characterisation of serpin polymers in vitro and in vivo.
title_fullStr Characterisation of serpin polymers in vitro and in vivo.
title_full_unstemmed Characterisation of serpin polymers in vitro and in vivo.
title_short Characterisation of serpin polymers in vitro and in vivo.
title_sort characterisation of serpin polymers in vitro and in vivo
work_keys_str_mv AT belorgeyd characterisationofserpinpolymersinvitroandinvivo
AT irvingj characterisationofserpinpolymersinvitroandinvivo
AT ekeowau characterisationofserpinpolymersinvitroandinvivo
AT freekej characterisationofserpinpolymersinvitroandinvivo
AT rousselb characterisationofserpinpolymersinvitroandinvivo
AT mirandae characterisationofserpinpolymersinvitroandinvivo
AT perezj characterisationofserpinpolymersinvitroandinvivo
AT robinsonc characterisationofserpinpolymersinvitroandinvivo
AT marciniaks characterisationofserpinpolymersinvitroandinvivo
AT crowtherd characterisationofserpinpolymersinvitroandinvivo
AT michelc characterisationofserpinpolymersinvitroandinvivo
AT lomasd characterisationofserpinpolymersinvitroandinvivo